David Becker to Treatment Outcome
This is a "connection" page, showing publications David Becker has written about Treatment Outcome.
Connection Strength
0.196
-
Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer Patients. Am J Clin Oncol. 2019 01; 42(1):12-16.
Score: 0.102
-
Improved outcomes with dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma. Gynecol Oncol. 2016 07; 142(1):25-29.
Score: 0.085
-
Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats. J Neurosurg. 2002 Jun; 96(6):1077-83.
Score: 0.008